Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's re…
An institutional-grade, numbers-driven thesis on TMO — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of August 7, 2026, TradersQuant's model rates Thermo Fisher Scientific Inc. (TMO) 64/100 with a 12-month base-case forecast of $597.67 — +3.0% versus the current price of $580.02. Thermo Fisher Scientific Inc. trades at $580.02 in the Healthcare sector, with a market capitalisation of $215.55B. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month analyst consensus price target for TMO is $597.67, implying +3.0% versus the current price. The model's 12-month scenario range runs from $570.81 (bear) to $755.26 (bull), with a base case of $633.97.
On the fundamentals, Thermo Fisher Scientific shows a P/E of 31.2, trailing revenue of $44.56B, revenue growth of +3.9% YoY, a dividend yield of 0.31%. This page also tracks TMO's short interest, institutional (smart-money) positioning and the options market — the same cross-signal view institutions watch.
TMO currently carries a TradersQuant composite score of 64/100, which we read as a neutral-to-watch signal. The Wall-Street analyst consensus is "Buy". Our 12-month price target of $597.67 implies +3.0% from $580.02. This is research, not financial advice — always combine it with your own judgement.
The analyst consensus price target for TMO is $597.67, about +3.0% versus the latest price of $580.02. Consensus is based on 43 analysts.
TradersQuant's 12-month model forecast for TMO is a base case of $633.97, ranging from $570.81 (bear) to $755.26 (bull), an expected return of +9.3%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for TMO over the next 12 months is $633.97 in the base case (bear $570.81, bull $755.26), versus today's price of $580.02. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for TMO — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates TMO's fair value at $597.67, implying +3.0% of expected upside versus the current price.
Yes — Thermo Fisher Scientific pays a dividend yielding 0.31% (about $1.80 per share annually).
Data and model outputs are for research only and are not financial advice. Figures update continuously.
